✦ LIBER ✦

The treatment of benign prostatic hyperplasia: a prospective, randomized clinical trial to be conducted by the American Urological Association

✍ Scribed by H. Logan Holtgrewe

Publisher: Springer-Verlag
Year: 1990
Tongue: English
Weight: 583 KB
Volume: 8
Category: Article
ISSN: 0724-4983
DOI: 10.1007/bf01580024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An american urological association prosp

An american urological association prospective, randomized clinical trial in the treatment of benign prostatic hyperplasia

✍ H. L. Holtgrewe 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 2 views

Estrogen reduction by aromatase inhibiti

Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: Results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane

✍ Radlmaier, Albert; Eickenberg, Hans U.; Fletcher, Matthew S.; Fourcade, Richard 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 799 KB

## BACKGROUND. The concept of estrogen withdrawal by an aromatase inhibitor in the treatment of benign prostatic hyperplasia (BPH) was assessed in a prospective, randomized, double-blind, placebo-controlled multicenter trial. METHODS. Two hundred and ninety-two patients with clinical symptoms of B